Maryland Medical Assistance Program - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription Drugs to Treat Serious Mental Illness
Hearing (Senate)
Email me when SB 490 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 490. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill bars the Maryland Medical Assistance Program from using prior authorization or step‑therapy/fail‑first rules for prescription drugs that treat adult enrollees with bipolar disorder, schizophrenia, major depression, PTSD, or medication‑induced movement disorders. It takes effect on July 1 2026 and remains in force for three years, ending June 30 2029. The goal is to speed access to needed mental‑health medications for Medicaid beneficiaries.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 490
3 free questions a day, no accountHearings
- Finance — Bill HearingFinance · Feb 17, 2026
History
- Hearing 2/17 at 1:00 p.m.
- First Reading Finance
Sponsors
- Lam · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 490 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 490 freeOr ask your AI assistant about SB 490 directly:
Add to Claude, ChatGPT or Cursor